radium has been researched along with Conus Medullaris Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, TM; Graff, JN | 1 |
| Badawi, JK | 1 |
2 review(s) available for radium and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
Topics: Androgen Receptor Antagonists; Androstenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Denosumab; Diphosphonates; Enzyme Inhibitors; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Pain; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Spinal Cord Compression; Zoledronic Acid | 2015 |
[Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
Topics: Bone Density Conservation Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Diphosphonates; Germany; Guideline Adherence; Humans; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radioisotopes; Radium; Spinal Cord Compression; Spinal Neoplasms; Strontium; Survival Rate; Urologic Neoplasms | 2012 |